Madison Wealth Partners’s AbbVie ABBV Stock Holding History

Madison Wealth Partners’s Portfolio ABBV Stock Details ABBV Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$927K	Buy	3,685 +1,126	+44%	+$242K	0.12%	98
2026 Q1	$556K	Buy	2,559 +742	+41%	+$165K	0.09%	103
2025 Q4	$415K	Buy	1,817 +796	+78%	+$181K	0.08%	116
2025 Q3	$236K	Buy	+1,021	New	+$208K	0.05%	155
2025 Q2	–	Sell	-1,095	Closed	-$229K	–	175
2025 Q1	$229K	Buy	+1,095	New	+$213K	0.06%	138
2024 Q4	–	Sell	-1,025	Closed	-$202K	–	153
2024 Q3	$202K	Buy	+1,025	New	+$191K	0.06%	144

Other funds holding ABBV

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return

Norges Bank Oslo, Norway $1T AUM

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Madison Wealth Partners's ABBV Position: Q2 2026 in Review

Madison Wealth Partners increased its AbbVie (ABBV) stake by 44% in Q2 2026, buying an estimated $242K and bringing the position to 3,685 shares worth $927K. The position accounts for 0.12% of the portfolio, ranked #98.

Madison Wealth Partners first reported a position in ABBV in Q3 2024 and has held it in 6 quarters since. 4,195 funds tracked by Wall St. Rank hold ABBV as of Q2 2026.

Madison Wealth Partners held 3,685 shares of AbbVie worth $927K as of Q2 2026.
Madison Wealth Partners bought 1,126 AbbVie shares in Q2 2026, an estimated $242K.
AbbVie made up 0.12% of Madison Wealth Partners's portfolio in Q2 2026, its #98 holding.
Madison Wealth Partners first reported a position in AbbVie in Q3 2024 and has held it in 6 quarters since.
4,195 funds tracked by Wall St. Rank held AbbVie as of Q2 2026.

Based on Madison Wealth Partners's 13F filing for Q2 2026, filed 12 Aug 2026.